经EGFR突变的NSCLC:治疗序列的路线图
1Institut Curie, Paris, France; Paris Saclay University, UVSQ, Faculté de Médecine Simone Veil, Versailles, France.
Med (New York, N.Y.)
|September 14, 2024
概括
HARMONi-A试验表明,IVONESCIMAB加化学疗法是非小细胞肺癌患者的新选择,这些患者在表皮生长因子受体 (EGFR) 氨酸激酶抑制剂后进展.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮表皮生长因子受体 (EGFR) 氨酸激酶抑制剂 (TKI) 是EGFR突变非小细胞肺癌 (NSCLC) 的标准治疗方法.
- 对第三代TKI获得的耐药性需要针对高级NSCLC制定新的治疗策略.
研究的目的:
- 评估IVONESCIMAB,一种针对PD-1和VEGF的新型双特异性抗体,与化疗结合使用.
- 评估IVONESCIMAB加化疗作为EGFR突变NSCLC患者第三代TKI失败后的二线治疗的疗效和安全性.
主要方法:
- HARMONi-A试验是一项临床研究,研究了IVONESCIMAB加化疗的疗效.
- 患者人群包括 EGFR 突变的 NSCLC 个体,他们之前已经接受了第三代 TKIs.
主要成果:
- 最近的HARMONi-A试验结果表明,组合治疗的结果很有希望.
- 针对PD-1和VEGF的Ivonescimab显示出作为一种新的治疗方法的潜力.
结论:
- 伊沃内西马布加化学疗法代表了EGFR突变NSCLC的潜在的新二线治疗选择.
- 这种组合疗法可以解决标准TKI治疗后进展的患者的未满足需求.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
